Malta - English - Medicines Authority

sanofi malta limited - vigabatrin - coated tablet - vigabatrin 500 mg - antiepileptics

Malta - English - Medicines Authority

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - vigabatrin - film-coated tablet - vigabatrin 500 mg - antiepileptics

Canada - English - Health Canada

lundbeck pharmaceuticals llc - vigabatrin - tablet - 500mg - vigabatrin 500mg - miscellaneous anticonvulsants

Canada - English - Health Canada

lundbeck pharmaceuticals llc - vigabatrin - powder for solution - 500mg - vigabatrin 500mg - miscellaneous anticonvulsants

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - vigabatrin - film-coated tablet - 500 milligram(s) - fatty acid derivatives; vigabatrin

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - vigabatrin - granules for oral solution - 500 milligram(s) - fatty acid derivatives; vigabatrin

European Union - English - EMA (European Medicines Agency)

orphelia pharma sas - vigabatrin - spasms, infantile; epilepsies, partial - antiepileptics, - kigabeq is indicated in infants and children from 1 month to less than 7 years of age for:treatment in monotherapy of infantile spasms (west's syndrome).treatment in combination with other antiepileptic medicinal products for patients with resistant partial epilepsy (focal onset seizures) with or without secondary generalisation, that is where all other appropriate medicinal product combinations have proved inadequate or have not been tolerated.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - vigabatrin 500mg;   - film coated tablet - 500 mg - active: vigabatrin 500mg   excipient: magnesium stearate microcrystalline cellulose opadry white oy-s-7298 povidone sodium starch glycolate - for the treatment of epilepsy which is not satisfactorily controlled by other antiepileptic medicines. for the management of infantile spasms (west syndrome). monotherapy for the treatment of partial seizure.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - vigabatrin 500mg;   - powder for oral solution - 500 mg - active: vigabatrin 500mg   excipient: povidone - for the treatment of epilepsy which is not satisfactorily controlled by other antiepileptic medicines. for the management of infantile spasms (west syndrome). monotherapy for the treatment of partial seizure.

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - vigabatrin - film-coated tablet - 500 milligram(s) - fatty acid derivatives; vigabatrin